Anders Olsson

31.9k total citations · 7 hit papers
301 papers, 23.6k citations indexed

About

Anders Olsson is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Anders Olsson has authored 301 papers receiving a total of 23.6k indexed citations (citations by other indexed papers that have themselves been cited), including 177 papers in Surgery, 70 papers in Endocrinology, Diabetes and Metabolism and 52 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Anders Olsson's work include Lipoproteins and Cardiovascular Health (153 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (54 papers) and Health Systems, Economic Evaluations, Quality of Life (33 papers). Anders Olsson is often cited by papers focused on Lipoproteins and Cardiovascular Health (153 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (54 papers) and Health Systems, Economic Evaluations, Quality of Life (33 papers). Anders Olsson collaborates with scholars based in Sweden, United States and Norway. Anders Olsson's co-authors include John Kjekshus, Ole Færgeman, Kalevi Pyörälà, Terje R. Pedersen, John J.V. McMurray, Lars Wilhelmsen, G Thorgeirsson, R. Scott Wright, Katherine M. Berg and HD White and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Anders Olsson

277 papers receiving 22.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1994 6.9k citations Anders Olsson, John J.V. McMurray et al. The Lancet profile →
Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome

2012 1.5k citations Anders Olsson, Philip J. Barter et al. profile →
Cholesterol Lowering With Simvastatin Improves Prognosis of Diabetic Patients With Coronary Heart Disease: A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)

1997 1.2k citations Kalevi Pyörälà, Terje R. Pedersen et al. profile →
Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial

2003 660 citations Hallvard Holdaas, Bengt Fellström et al. The Lancet profile →
PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial

2014 562 citations Anders Olsson et al. The Lancet profile →
Effect of a Monoclonal Antibody to PCSK9 on Low-Density Lipoprotein Cholesterol Levels in Statin-Intolerant Patients

2012 369 citations Anders Olsson et al. profile →
Baseline and on-statin treatment lipoprotein(a) levels for prediction of cardiovascular events: individual patient-data meta-analysis of statin outcome trials

2018 365 citations Terje R. Pedersen, Anders Olsson et al. The Lancet profile →

Peers

Countries citing papers authored by Anders Olsson

Since Specialization

Citations

This map shows the geographic impact of Anders Olsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Olsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Olsson more than expected).

Fields of papers citing papers by Anders Olsson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anders Olsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Olsson. The network helps show where Anders Olsson may publish in the future.

Co-authorship network of co-authors of Anders Olsson

This figure shows the co-authorship network connecting the top 25 collaborators of Anders Olsson. A scholar is included among the top collaborators of Anders Olsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anders Olsson. Anders Olsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Empowering Regional Conservation: Genetic Diversity Assessments as a Tool for Eelgrass Management 2025 ·Molecular Ecology ·E. C. Faust, (unknown), Anders Olsson, (unknown), Per‐Olav Moksnes, Marlene Jahnke	3
2	Tasquinimod Modulates Suppressive Myeloid Cells and Enhances Cancer Immunotherapies in Murine Models 2014 ·Cancer Immunology Research ·Li Shen, Anette Sundstedt, Michael J. Ciesielski, Kiersten Marie Miles, (unknown), Remi Adelaiye‐Ogala, Ashley Orillion, Eric Ciamporcero, Swathi Ramakrishnan, Leigh Ellis, Robert A. Fenstermaker, Scott I. Abrams, Helena Eriksson, Tomas Leanderson, Anders Olsson, Роберто Пили	74
3	Languages of exile : migration and multilingualism in twentieth-century literature 2013 ·(unknown), Anders Olsson	2
4	Tasquinimod Is an Allosteric Modulator of HDAC4 Survival Signaling within the Compromised Cancer Microenvironment 2012 ·Cancer Research ·John T. Isaacs, Lizamma Antony, Susan L. Dalrymple, W. Nathaniel Brennen, (unknown), Hans J. Hammers, Michel D. Wissing, Sushant K. Kachhap, Jun Luo, Li Xing, Per Björk, Anders Olsson, (unknown), Tomas Leanderson	89
5	Tidskriften Pedagogik Forskning i Sverige: Tillbakablick och lägesbeskrivning 2012 ·Bulletin Monumental ·Anders Olsson	1
6	Abstract 18079: Among CHD Patients in the IDEAL Study, Those with Elevated Levels of Alanine Aminotransferase at Baseline Had a Lower Rate of Major Coronary Events 2011 ·Circulation ·Matti J. Tikkanen, Rana Fayyad, Rachel Laskey, Ingar Holme, Ole Færgeman, Anders Olsson, Christina Lindahl, John J.P. Kastelein, Mogens Lytken Larsen, Terje R. Pedersen, (unknown)	1
7	Japaner, japaner… Kulturens betydelse vid övergång till Toyotainspirerad lean produktion i ett japanskägt företag i Sverige 2011 ·KTH Publication Database DiVA (KTH Royal Institute of Technology) ·(unknown), Anders Olsson	1
8	Use of the Thyroid Hormone Analogue Eprotirome in Statin-Treated Dyslipidemia 2010 ·Obstetrical & Gynecological Survey ·Paul W. Ladenson, Jens D. Kristensen, E. Chester Ridgway, Anders Olsson, Bo Carlsson, Irwin Klein, John D. Baxter, Bo Angelin	5
9	Lipoprotein predictors of cardiovascular events in statin-treated patients with coronary heart disease. Insights from the Incremental Decrease in End-points through Aggressive Lipid-lowering Trial (IDEAL) 2008 ·Annals of Medicine ·Ingar Holme, Nilo B. Cater, Ole Færgeman, John J.P. Kastelein, Anders Olsson, Matti J. Tikkanen, Mogens Lytken Larsen, Christina Lindahl, Terje R. Pedersen, (unknown)	44
10	Power and the tourism curriculum 2007 ·Lund University Publications (Lund University) ·Anders Olsson, (unknown)	0
11	Abstract 3357: Superiority of ApoB/ApoA1 Ratio for Predicting Cardiovascular Risk in Pooled Analyses of the Incremental Decrease in Endpoints through Aggressive Lipid-Lowering (IDEAL) and Treating to New Targets (TNT) Trials 2006 ·Circulation ·John J.P. Kastelein, Ingar Holme, Philip J. Barter, Anders Olsson, Nilo B. Cater, David A. DeMicco, Michael Gaffney, Michael Szarek, John C. LaRosa, Terje R. Pedersen	2
12	Improving allograft survival 2005 ·Nephrology Dialysis Transplantation ·Hallvard Holdaas, Bengt Fellström, Alan G. Jardine, Edward Cole, Gudrun Nyberg, Carola Grönhagen‐Riska, Bart Maes, Hans‐Hellmut Neumayer, Sören Madsen, (unknown), Terje Pedersen, Anders Olsson, Hendrica Belge, Philippe Gailly, (unknown), Johannes Loffing, Renaud Beauwens, Olivier Devuyst	1
13	Cardiovascular Risk and Renal Transplantation: Post Hoc Analyses of the Assessment of Lescol in Renal Transplantation (ALERT) Study 2005 ·American Journal of Kidney Diseases ·Alan G. Jardine, Bengt Fellström, John O. Logan, Edward Cole, Gudrun Nyberg, Carola Grönhagen‐Riska, Sören Madsen, Hans‐Hellmut Neumayer, Bart Maes, Patrice M. Ambühl, Anders Olsson, Terje Pedersen, Hallvard Holdaas	94
14	Anders Mortensen, Tradition och originalitet hos Gunnar Ekelöf : Symposion. Stockholm/Stehag 2000 2000 ·KTH Publication Database DiVA (KTH Royal Institute of Technology) ·Anders Olsson	0
15	En ny sorts studie behövs. 1999 ·Läkartidningen ·Anders Olsson	0
16	Antioxidant state and mortality from coronary heart disease in lithuanian and swedish men: concomitant cross sectional study of men aged 50 1997 ·BMJ ·Margareta Kristenson, Bo Ziedén, Zita Aušrelė Kučinskienė, (unknown), (unknown), Liselotte Schäfer Elinder, Björn Bergdahl, (unknown), Henrikas Čalkauskas, Anders Olsson	152
17	Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) breakdown → 1994 ·The Lancet ·Anders Olsson, John J.V. McMurray, G Thorgeirsson, Christian Spaulding, Jim Slattery, Kalevi Pyörälà, Ole Færgeman, R. Scott Wright, Katherine M. Berg, Lars Wilhelmsen, T.R. Pedersen, T. A. Miettinen, HD White, John Kjekshus, Michael Gnant	6928
18	The effect of probucol on femoral atherosclerosis: The Probucol Quantitative Regression Swedish Trial (PQRST) 1994 ·The American Journal of Cardiology ·Göran Walldius, Uno Erikson, Anders Olsson, L. Bergstrand, Karin Hådell, Jan Johansson, L. Kaijser, Claes Lassvik, Jörgen Mölgaard, Sven Nilsson, Liselotte Schäfer Elinder, G Stenport, Ingar Holme	180
19	Development of femoral atherosclerosis in hypercholesterolemic patients during treatment with cholestyramine and probucol/placebo: Probucol quantitative regression Swedish trial (PQRST): A status report 1988 ·The American Journal of Cardiology ·Göran Walldius, Lars A. Carlson, Uno Erikson, Anders Olsson, Jan Johansson, Jörgen Mölgaard, Sven Nilsson, G Stenport, L. Kaijser, Claes Lassvik, Ingar Holme	48
20	Separation of two serum very low density lipoprotein fractions using starch block electrophoresis 1979 ·Scandinavian Journal of Clinical and Laboratory Investigation ·Anders Olsson	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact